SEdation Versus General Anesthesia for Endovascular Therapy in Acute Ischemic Stroke

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 260 participants.

Also called NCT03263117

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 260 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03263117
Other papers using this trial's data
  • Sedation vs General Anesthesia for Endovascular Therapy in Acute Ischemic Stroke: The SEGA Randomized Clinical Trial JAMA neurology, 2025-12-01 DOI, PubMed 41082222, PMC12687099 Not in the PMC Open Access subset.

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03263117. Randomized; single masking; primary purpose treatment. Start 2018-07-01 (actual); primary completion 2023-04-22 (actual). Results posted on 2024-09-05.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
SEdation Versus General Anesthesia for Endovascular Therapy in Acute Ischemic Stroke
Acronym
SEGA
Condition
Stroke
Intervention (Drug)
Sedation
Intervention (Drug)
General Anesthesia (GA)
Intervention (Procedure)
Intra-arterial Thrombectomy
Lead sponsor
The University of Texas Health Science Center, Houston (class: other)
Collaborator
Stryker Neurovascular (class: industry)

Record details

Record id
cardio:ct-nct03263117
Content hash
f36917e486c0caab8e07ca63a8c3cb82838542e57c2af20fb4dbc1a7d26be707